NEW YORK CITY: Pfizer faces growing political pressure at home and in Britain as speculation mounts on whether the US pharmaceutical giant will sweeten its buyout offer for British company AstraZeneca.

Late this week, two US governors pressed Pfizer about the impact on jobs in their states, while a US senator called for an overhaul of the tax code to discourage deals like Pfizer is pursuing, which would move the new company’s headquarters to Britain, avoiding paying billion of dollars in US taxes.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details